EUVIMED · CrossrefJournal
Cancer Immuno Perspectives
ISSN 3134-6510 · MediMosaic Publishing Corporation Limited
Latest articles
Beyond PD-L1: Stratification Logic and Microenvironmental Functional Defects in Gynecologic Cancer Immunotherapy
Beyond the “cold tumor” label: dimensional heterogeneity of immune resistance and dimension-matched combination strategies in gynecologic cancers
From Cell States to Spatial Ecotypes: Spatial Organization as an Independent Explanatory Layer of Immunotherapy Resistance
Metabolic Reprogramming as an Immunosuppressive Force in the Tumor Microenvironment: From Nutrient Competition to Epigenetic Fixation
Nanodelivery-mediated Remodeling of Tumor Stromal Cells to Reverse the Immunosuppressive Tumor Microenvironment: From a Cell-Centric View to a Constraint-based Conceptual Framework
Exploring Immune-Related Gene Signatures for Prognostic Modeling and Immunotherapy Guidance in Gallbladder Cancer
Immune-Related Biomarkers in Cancer: Development, Validation, and Challenges in Clinical Practice—A Systematic Review
Metabolic Competition in the Tumor Microenvironment as a Driver of Immune Dysfunction and Therapy Failure
The Tumor Microenvironment as a Driver of Immune Escape and Therapeutic Resistance in Cancer
Tumor Microenvironment and Immune Evasion Mechanisms
Targeting CD70 in Solid Tumors: From Epigenetic Heterogeneity to Next-Generation CAR T Cell Therapies
How ALPK1 Activation Orchestrates Antitumour Immunity: Mechanisms and Therapeutic Opportunities
In Vivo Reprogramming Strategies to Enhance Tumor Immunogenicity and T Cell Immunity
First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Systematic Review and Meta-analysis of Baseline Neutrophil-Lymphocyte Ratio Predicting Prognosis in Cancer Patients Treated with Immune Checkpoint Inhibitors
EUVIMED